Login / Signup

Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.

Félix Guerrero-RamosDaniel A González-PadillaAlejandro González-DíazFederico de la Rosa-KehrmannAlfredo Rodríguez-AntolínBrant A InmanFelipe Villacampa-Aubá
Published in: World journal of urology (2022)
EudraCT 2016-001186-85. Date of registration: 17 March 2016.
Keyphrases
  • muscle invasive bladder cancer
  • locally advanced
  • double blind
  • clinical trial
  • chemotherapy induced